Human BPIFB1 Antibody

Catalog #: MAB10195 Datasheet / COA / SDS

Catalog #	Availability	Size / Price	Qty
MAB10195-100
MAB10195-SP

Detection of Human BPIFB1 by Western Blot.

1 Image

All BPIFB1 Antibodies

Product Details

Supplemental Products

Reviews

Summary Data Examples Preparation and Storage Reconstitution Calculator Background Product Datasheets Related Research Areas

Human BPIFB1 Antibody Summary

Species Reactivity

Human

Specificity

Detects human BPIFB1 in direct ELISAs.

Source

Monoclonal Mouse IgG_2B Clone # 1023938

Purification

Protein A or G purified from hybridoma culture supernatant

Immunogen

Human embryonic kidney cell, HEK293-derived human BPIFB1
Thr22-Gln484
Accession # Q8TDL5

Formulation

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied either lyophilized or as a 0.2 µm filtered solution in PBS.

Label

Unconjugated

Applications

Recommended Concentration

Sample

Western Blot

2 µg/mL

Human lung tissue

Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.

Scientific Data

Western Blot

View Larger

Detection of Human BPIFB1 by Western Blot. Western blot shows lysates of human lung tisue. PVDF membrane was probed with 2 µg/mL of Mouse Anti-Human BPIFB1 Monoclonal Antibody (Catalog # MAB10195) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (HAF018). A specific band was detected for BPIFB1 at approximately 54 kDa (as indicated). This experiment was conducted under reducing conditions and using Western Blot Buffer Group 1.

Reconstitution Calculator

Preparation and Storage

Reconstitution

Reconstitute at 0.5 mg/mL in sterile PBS.

Shipping

Lyophilized product is shipped at ambient temperature. Liquid small pack size (-SP) is shipped with polar packs. Upon receipt, store immediately at the temperature recommended below.

Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.

12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.

Background: BPIFB1

BPIFB1 (BPI fold-containing family B member 1), also named LPLUNC1, is a member of the BPI-fold (BPIF) containing/Plunc (palate, lung, and nasal epithelium clone) superfamily of putative innate defense molecules which are predominantly expressed in regions of the oral cavity, nasopharynx and upper respiratory tract (1, 2). BPIF proteins exist as two subgroups, BPIFA (formally SPLUNCs) and BPIFB (formally LPLUNCs) (1, 3). BPIFA proteins have structural homology to the N-terminal domain of BPI whereas BPIFB proteins have structural homology to both domains of BPI (2). Human BPIFB1 cDNA encodes a 484 amino acid (aa) precursor protein with a putative 21 aa signal peptide and a 463 aa mature chain. The mature human BPIFB1 shares approximately 57% and 56% aa sequence identity with mouse and rat BPIFB1, respectively. BPIF proteins appear to exhibit distinct tissue and cell specific expression patterns with various family members, being localized to a number of glandular structures within the upper respiratory tract, nasopharyngeal regions and oral cavity where they are secreted from these tissues and are found in high levels in saliva and nasal and respiratory lining fluids (2). BPIFB1 plays a role in diverse functions, including neutralizing endotoxin (LPS) in septic shock patients, inhibition of endothelial cell growth, dendritic cell maturation, as an anti-angiogenic, chemoattractant or opsonization agent (2). Although less characterized as BPIFA1, BPIFB1 may also function as an innate immune molecule sensing and responding to Gram-negative bacteria (4). BPIFA1 and BPIFB1 expression was increased in late stage chronic obstructive pulmonary disease (COPD) patients, and elevated levels correlate with disease severity (5). BPIFB1 is also upregulated in cystic fibrosis (CF) lung disease and may play a role in the pathogenesis of the disease (6).

References

Bingle, C. D. and C. J. Craven (2002) Hum. Mol. Genet. 11:937.
Alves, D. B. et al. (2017) Braz. Oral Res. 31:e6.
Bingle, L. et al. (2012) Histochem. Cell Biol. 138:749.
Balakrishnan, A. et al. (2013) Innate Immun. 19:339.
De Smet, E. G. et al. (2017) Int. J. Chron. Obstruct. Pulmon. Dis. 13:11.
Saferali, A. et al. (2015) Am. J. Respir. Cell. Mol. Biol. 53:607.

Long Name

BPI Fold Containing Family B Member 1

Entrez Gene IDs

92747 (Human); 228801 (Mouse); 499926 (Rat)

Alternate Names

bA49G10.6; BPIFB1; C20orf114; chromosome 20 open reading frame 114; dJ1187J4.1; long palate, lung and nasal epithelium carcinoma associated 1; long palate, lung and nasal epithelium carcinoma-associated protein 1; LPLUNC1; MGC14597; VEMSGP; Von Ebner minor salivary gland protein